NCT07472777 2026-03-16
Long-term Efficacy of Modified Guilu Erxian Glue for Myasthenia Gravis
Beijing University of Chinese Medicine
Completed
Clinical Trials
85 trialsNCT06718855 2026-02-19
MYCOG
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Completed
NCT04818671 2026-01-22
ADAPTSC+
argenx
Phase 3 Completed
NCT06764160 2026-01-15
ECU-MG-304
Alexion Pharmaceuticals, Inc.
Phase 3 Completed
NCT07319689 2026-01-06
Predictors of Myasthenia Gravis Outcome Following Thoracoscopic Thymectomy: Comparative Study Between Thymomatous and Non-Thymomatous Patients
Tanta University
Completed
NCT07291713 2025-12-18
Psychological Health and Adverse Childhood Experiences in Myasthenia Gravis: Online Mental Health BMI Learning Program
Shin Kong Wu Ho-Su Memorial Hospital
Phase NA Completed
NCT05451212 2025-11-10
Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis
Cabaletta Bio
Phase 1 Completed
NCT05681715 2025-11-06
A Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participants With Generalized Myasthenia Gravis (gMG)
UCB Pharma
Phase 3 Completed
NCT04980495 2025-11-05
ADAPT NXT
argenx
Phase 3 Completed
NCT06471361 2025-09-26
A Study to Evaluate the Safe and Effective Use of a Zilucoplan Auto-injector by Study Participants With Generalized Myasthenia Gravis
UCB Pharma
Phase 3 Completed
NCT05230082 2025-09-18
Acupuncture in Myasthenia Gravis (AcuMG)
HealthPartners Institute
Phase NA Completed
NCT04431895 2025-09-16
Safety And Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis: A Pilot Study
Huashan Hospital
Phase EARLY_PHASE1 Completed
NCT07154095 2025-09-04
A Single-Center, Randomized, Open-Label, Two-Sequence, Two-Period, Crossover Study Comparing the Pharmacokinetics and Safety of Pyridostigmine Sustained-Release and Immediate-Release Tablets Following Single and Multiple Doses in Healthy Chinese Participants
West China Second University Hospital
Phase 1 Completed
NCT05514873 2025-09-03
An Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Zilucoplan in Participants With Generalized Myasthenia Gravis Who Were Previously Receiving Intravenous Complement Component 5 Inhibitors
UCB Pharma
Phase 3 Completed
NCT05979688 2025-08-08
Yogic Breathing Exercise for People With Amyotrophic Lateral Sclerosis
University of Alabama at Birmingham
Phase NA Completed
NCT04115293 2025-07-16
RAISE
UCB Pharma
Phase 3 Completed
NCT07022028 2025-06-18
GUIMAUVE
Poitiers University Hospital
Completed
NCT05737160 2025-05-23
Study of Telitacicept in Generalized Myasthenia Gravis
RemeGen Co., Ltd.
Phase 3 Completed
NCT04728425 2025-04-27
MG_SCIG
University Health Network, Toronto
Phase 2 Completed
NCT04678115 2025-04-22
Clinical Trial Comparing Two Non-Surgical Treatments for Severe Blepharoptosis
Massachusetts Eye and Ear Infirmary
Phase NA Completed
NCT04650854 2025-04-18
A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis
UCB Pharma
Phase 3 Completed
NCT06436768 2025-04-02
Efficacy and Safety of Sugammadex in Thoracoscopy Thymectomy for Chinese Adults With Myasthenia Gravis
Beijing Tongren Hospital
Phase NA Completed
NCT06381284 2025-03-25
Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-Assessment
ZS Associates
Completed
NCT05566964 2025-03-10
Descriptive Analysis of Real-world Data Collected with ME&MGopen
Ad scientiam
Completed
NCT06860347 2025-03-06
Biomarkers for Fatigue in Patients with Myasthenia Gravis
Leiden University Medical Center
Completed
NCT06860360 2025-03-06
Artificial Intelligence for the Analysis of Video Data of Facial Movement, with a Focus on Myasthenia Gravis
Leiden University Medical Center
Completed
NCT03759366 2024-12-11
A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG)
Alexion Pharmaceuticals, Inc.
Phase 3 Completed
NCT02950155 2024-10-26
Rinomax
Karolinska Institutet
Phase 3 Completed
NCT05890833 2024-09-19
The Risk of Falls Index for Patients With Neuromuscular Disorders
LMU Klinikum
Completed
NCT02965573 2024-08-28
A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness
argenx
Phase 2 Completed
NCT03920293 2024-05-28
Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc.
Phase 3 Completed
NCT03304054 2024-03-12
Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG
Catalyst Pharmaceuticals, Inc.
Phase 3 Completed
NCT06256172 2024-02-13
Medlink
Olawuyi Racett Nigeria Ltd
Phase NA Completed
NCT03863080 2023-12-20
A Study of RVT-1401 in Myasthenia Gravis (MG) Patients
Immunovant Sciences GmbH
Phase 2 Completed
NCT05945784 2023-12-06
Exploring Accessible Beauty for Individuals With Upper Extremity Deficits
Casa Colina Hospital and Centers for Healthcare
Completed
NCT04695379 2023-10-06
CO-MY-COVID
University Hospital, Bordeaux
Completed
NCT04124965 2023-09-05
A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis
UCB Pharma
Phase 3 Completed
NCT03770403 2023-07-14
ADAPT+
argenx
Phase 3 Completed
NCT03772587 2023-06-27
A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis
Momenta Pharmaceuticals, Inc.
Phase 2 Completed
NCT04159805 2023-06-02
A Study of TAK-079 in People With Generalized Myasthenia Gravis
Takeda
Phase 2 Completed
NCT04346888 2023-03-08
A Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG Patients
Harbour BioMed (Guangzhou) Co. Ltd.
Phase 2 Completed
NCT05039190 2023-03-08
MG
Harbour BioMed (Guangzhou) Co. Ltd.
Phase 3 Completed
NCT04735432 2023-02-28
ADAPTsc
argenx
Phase 3 Completed
NCT02774239 2023-02-21
SCIG-MG
University of Alberta
Phase 3 Completed
NCT05694234 2023-01-23
Influences of Sugammadex on Postoperative Progress in Patients With Myasthenia Gravis Undergoing Video-assisted Thoracoscopic Thymectomy: Retrospective Study
Yonsei University
Completed
NCT03205306 2023-01-10
Myasthenia Gravis and Psyche
Charite University, Berlin, Germany
Completed
NCT03315130 2022-07-27
Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis
UCB Pharma
Phase 2 Completed
NCT05408702 2022-06-07
MYaEX
Institut de Myologie, France
Completed
NCT05380128 2022-05-18
Association Study Between VDR Gene Polymorphisms and Risk and Features of MG in Han Chinese Population
Beijing Tongren Hospital
Completed
NCT01727193 2022-04-14
The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy
First Affiliated Hospital, Sun Yat-Sen University
Phase 3 Completed